- Home
- CFFN vs NAGE Comparison
CFFN vs NAGE Comparison
Compare CFFN & NAGE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CFFN
- NAGE
- Stock Information
- Founded
- CFFN 1893
- NAGE 1999
- Country
- CFFN United States
- NAGE United States
- Employees
- CFFN N/A
- NAGE N/A
- Industry
- CFFN Savings Institutions
- NAGE Medicinal Chemicals and Botanical Products
- Sector
- CFFN Finance
- NAGE Health Care
- Exchange
- CFFN Nasdaq
- NAGE Nasdaq
- Market Cap
- CFFN 813.3M
- NAGE 861.0M
- IPO Year
- CFFN 1999
- NAGE N/A
- Fundamental
- Price
- CFFN $6.17
- NAGE $10.12
- Analyst Decision
- CFFN Hold
- NAGE Strong Buy
- Analyst Count
- CFFN 1
- NAGE 3
- Target Price
- CFFN $6.50
- NAGE $17.00
- AVG Volume (30 Days)
- CFFN 682.1K
- NAGE 1.4M
- Earning Date
- CFFN 07-23-2025
- NAGE 08-06-2025
- Dividend Yield
- CFFN 5.51%
- NAGE N/A
- EPS Growth
- CFFN N/A
- NAGE N/A
- EPS
- CFFN 0.47
- NAGE 0.22
- Revenue
- CFFN $192,483,000.00
- NAGE $116,303,000.00
- Revenue This Year
- CFFN $10.56
- NAGE $26.44
- Revenue Next Year
- CFFN $11.73
- NAGE $20.06
- P/E Ratio
- CFFN $13.13
- NAGE $47.48
- Revenue Growth
- CFFN N/A
- NAGE 35.90
- 52 Week Low
- CFFN $4.90
- NAGE $2.81
- 52 Week High
- CFFN $7.20
- NAGE $14.69
- Technical
- Relative Strength Index (RSI)
- CFFN 57.17
- NAGE N/A
- Support Level
- CFFN $5.74
- NAGE N/A
- Resistance Level
- CFFN $5.85
- NAGE N/A
- Average True Range (ATR)
- CFFN 0.12
- NAGE 0.00
- MACD
- CFFN 0.00
- NAGE 0.00
- Stochastic Oscillator
- CFFN 77.97
- NAGE 0.00
About CFFN Capitol Federal Financial Inc.
Capitol Federal Financial Inc is a bank holding company that operates through its wholly-owned subsidiary bank, Capitol Federal Savings Bank. The bank is a community-oriented financial institution that offers a variety of financial services through tens of locations. It primarily serves metropolitan areas within the state of Kansas. The bank performs traditional banking functions such as deposit-taking activities and investing that money in first-lien residential mortgages. It also participates in commercial real estate loans with other lenders, investing those funds in various securities. The vast majority of the bank's loan portfolio is in originated one- to four-family real estate loans. Its primary source of income is net interest income.
About NAGE Niagen Bioscience Inc. Common Stock
Niagen Bioscience Inc is the leader in NAD+ (nicotinamide adenine dinucleotide) science and healthy-aging research. It is dedicated to advancing healthspan through precision science and innovative NAD+-boosting solutions. It is is clinically proven to increase NAD+ levels efficiently and effectively, and is the key ingredient powering our suite of Niagen brands.